| Literature DB >> 35136499 |
S Babu Peter1, V Raghu Nandhan1.
Abstract
Background: 31-Phosphorus magnetic resonance spectroscopy (31-P MRS) has excellent potential for clinical neurological practice because of its noninvasive in-vivo assessment of cellular energy metabolism and the indirect evaluation of the phospholipid composition of the cell membrane, intracellular pH, and intracellular Mg2+ concentration. Purpose: The aim of this study was to evaluate the metabolic characteristics of glioma and metastases using 31-P MRS and assess utility to differentiate both. Study Type: Prospective study. Population: Fifteen consecutive patients with brain tumor. Field Strength/Sequence: Three-tesla magnetic resonance imaging/three-dimensional MRS imaging sequence. Statistical Tests: Unpaired sample t -test, and one-way analysis of variance with Tukey's post-hoc test.Entities:
Keywords: 31-phosphorus multinuclear spectroscopy; glioma; metastases; nuclear magnetic spectroscopy
Year: 2022 PMID: 35136499 PMCID: PMC8817830 DOI: 10.1055/s-0041-1741090
Source DB: PubMed Journal: Indian J Radiol Imaging ISSN: 0970-2016
Fig. 1Spectral waveform of various phospholipid metabolites in normal brain parenchyma.
Mean integral values, standard deviation, and p -values of various phospholipid metabolites with ratios and statistical significance
| Metabolites | Tumor | Periphery | Normal | Significance | ||
|---|---|---|---|---|---|---|
| PCr | 660 ± 465 | 578 ± 469 | 663 ± 597 | 0.124 | 0.884 | – |
| Pi | 251 ± 178 | 179 ± 127 | 167 ± 99 | 1.609 | 0.212 | – |
| PME | 235 ± 84 | 297 ± 323 | 361 ± 392 | 0.678 | 0.513 | – |
| PDE | 228 ± 140 | 221 ± 198 | 205 ± 136 | 0.081 | 0.922 | – |
| ATP | 894 ± 548 | 851 ± 724 | 865 ± 758 | 0.016 | 0.984 | – |
| PME/PDE | 1.96 ± 2.33 | 1.90 ± 2.19 | 3.58 ± 5.04 | 1.126 | 0.334 | – |
| PME/Pi | 1.22 ± 0.72 | 1.74 ± 1.01 | 2.28 ± 1.44 | 3.468 | 0.041 | + |
| PME/pCr | 0.45 ± 0.22 | 0.49 ± 0.23 | 0.57 ± 0.24 | 1.17 | 0.320 | – |
| PME/ATP | 0.31 ± 0.14 | 0.34 ± 0.18 | 0.42 ± 0.17 | 1.708 | 0.194 | – |
| PDE/Pi | 1.06 ± 0.63 | 1.30 ± 0.57 | 1.44 ± 1.04 | 0.895 | 0.416 | – |
| PDE/pCr | 0.37 ± 0.20 | 0.40 ± 0.21 | 0.34 ± 0.20 | 0.318 | 0.730 | – |
| PDE/ATP | 0.26 ± 0.13 | 0.27 ± 0.11 | 0.26 ± 0.15 | 0.031 | 0.970 | – |
| PCr/Pi | 2.76 ± 0.73 | 3.59 ± 1.77 | 4.13 ± 1.75 | 3.23 | 0.050 | + |
| PCr/ATP | 0.73 ± 0.15 | 0.70 ± 0.14 | 0.78 ± 0.13 | 1.29 | 0.286 | – |
| ATP/Pi | 4.02 ± 1.87 | 5.07 ± 2.26 | 5.31 ± 2.35 | 1.504 | 0.234 | – |
| Pi/ATP | 0.28 ± 0.09 | 0.22 ± 0.06 | 0.19 ± 0.08 | 3.244 | 0.049 | + |
| pH | 7.12 ± 0.10 | 7.06 ± 0.07 | 7.04 ± 0.06 | 4.021 | 0.025 | + |
Abbreviations: ATP, adenosine triphosphate; PCr, phosphocreatine; PDE, phosphodiesters; pH, hydrogen ion concentration; Pi, inorganic phosphate; PME, phosphomonoesters.
Mean, standard deviation, and p -value with various phospholipid ratios in glioma and metastasis with voxel of interest placed within the contrast-enhancing site of the lesion
| Metabolites | Glioma | Metastasis | Significance | |||
|---|---|---|---|---|---|---|
| Lesion | Periphery | Lesion | Periphery | |||
| PCr | 777 ± 565 | 663 ± 623 | 484 ± 179 | 465 ± 52 | 0.247 |
|
| Pi | 298 ± 215 | 223 ± 151 | 181 ± 72 | 119 ± 50 | 0.227 |
|
| PME | 220 ± 84 | 324 ± 428 | 256 ± 85 | 262 ± 111 | 0.428 |
|
| PDE | 283 ± 135 | 288 ± 240 | 144 ± 106 | 132 ± 68 | 0.053 |
|
| ATP | 1,056 ± 666 | 1,028 ± 938 | 652 ± 119 | 614 ± 122 | 0.170 |
|
| PME/PDE | 0.96 ± 0.63 | 0.97 ± 0.55 | 3.45 ± 3.18 | 3.13 ± 2.98 | 0.114 |
|
| PME/Pi | 0.94 ± 0.50 | 1.18 ± 0.70 | 1.63 ± 0.86 | 2.49 ± 0.89 | 0.070 |
|
| PME/pCr | 0.35 ± 0.17 | 0.40 ± 0.20 | 0.58 ± 0.23 | 0.60 ± 0.25 | 0.047 | + |
| PME/ATP | 0.25 ± 0.12 | 0.26 ± 0.13 | 0.41 ± 0.14 | 0.46 ± 0.19 | 0.034 | + |
| PDE/Pi | 1.09 ± 0.43 | 1.29 ± 0.35 | 1.01 ± 0.90 | 1.32 ± 0.82 | 0.853 | – |
| PDE/pCr | 0.41 ± 0.15 | 0.49 ± 0.21 | 0.32 ± 0.26 | 0.28 ± 0.15 | 0.439 | – |
| PDE/ATP | 0.29 ± 0.11 | 0.30 ± 0.08 | 0.21 ± 0.16 | 0.23 ± 0.13 | 0.272 | – |
| pCr/Pi | 2.73 ± 0.76 | 2.86 ± 1.00 | 2.81 ± 0.75 | 4.57 ± 2.17 | 0.844 | – |
| pCr/ATP | 0.72 ± 0.07 | 0.64 ± 0.15 | 0.75 ± 0.22 | 0.77 ± 0.10 | 0.704 | – |
| ATP/Pi | 3.78 ± 0.97 | 4.37 ± 0.84 | 4.38 ± 2.83 | 6.01 ± 3.23 | 0.560 | – |
| Pi/ATP | 0.28 ± 0.06 | 0.24 ± 0.05 | 0.29 ± 0.13 | 0.19 ± 0.05 | 0.797 | – |
Abbreviations: ATP, adenosine triphosphate; PCr, phosphocreatine; PDE, phosphodiesters; Pi, inorganic phosphate; PME, phosphomonoesters.
Fig. 2Bar chart showing pH values of lesion and peripheral edema of glioma and metastases.
Mean, standard deviation, and p -value of biochemical pH value in glioma and metastasis in contrast-enhanced area and perilesional edema
| pH | Glioma | Metastasis | Significance | |
|---|---|---|---|---|
| Mean and SD | Mean and SD | |||
| Lesion | 7.12 ± 0.10 | 7.12 ± 0.12 | 0.821 | – |
| Peripheral edema | 7.09 ± 0.06 | 7.02 ± 0.05 | 0.03 | + |
Abbreviations: pH, hydrogen ion concentration; SD, standard deviation.
Fig. 3( A ) Axial T2-weighted images show mixed intense lesion noted in the body of corpus callosum (histopathologically proven Grade II glioma). ( B ) Postcontrast subtracted images show heterogeneous contrast enhancement. ( C and D ) Axial chemical shift imaging sequence of 31-phosphorus multinuclear spectroscopy and the spectroscopic integral values of various phospholipid metabolites.
Fig. 4( A ) Postcontrast images show heterogeneous enhancing mass lesion in left temporal lobe (histopathologically proven Grade IV glioma). ( B and C ) Axial chemical shift imaging sequence of 31-phosphorus multinuclear spectroscopy and the spectroscopic integral values of various phospholipid metabolites.
Fig. 5( A ) Axial T2-weighted images show multiple (two) mixed intensity lesion noted in bilateral high frontal region with surrounding disproportionate edema (cerebral metastasis/known case of Ca lung). (B) Postcontrast images show heterogeneous contrast enhancement. ( C and D ) Axial chemical shift imaging sequence of 31-phosphorus multinuclear spectroscopy and the spectroscopic integral values of various phospholipid metabolites.
Fig. 6( A ) Axial postcontrast images show heterogeneous enhancing mass lesion in right frontal and parietal lobes (cerebral metastasis/known case of Ca lung). ( B and C ) Axial chemical shift imaging sequence of 31-phosphorus multinuclear spectroscopy and the spectroscopic integral values of various phospholipid metabolites.